Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism
Lancet Microbe
.
2021 Aug;2(8):e347-e348.
doi: 10.1016/S2666-5247(21)00126-9.
Epub 2021 Jun 18.
Authors
Akaninyene Otu
1
2
,
Egbe Osifo-Dawodu
3
,
Phionah Atuhebwe
4
,
Emmanuel Agogo
5
,
Bassey Ebenso
6
Affiliations
1
Department of Internal Medicine, College of Medical Sciences, University of Calabar, Calabar 1115, Nigeria.
2
Foundation for Healthcare Innovation and Development, Calabar, Nigeria.
3
Anadach Consulting Group, College Park, MD, USA.
4
World Health Organization's Regional Office for Africa, Brazzaville, Republic of the Congo.
5
Resolve to Save Lives, Abuja, Nigeria.
6
Nuffield Centre for International Health and Development, Leeds Institute for Health Sciences, University of Leeds, Leeds, UK.
PMID:
34179857
PMCID:
PMC8213358
DOI:
10.1016/S2666-5247(21)00126-9
No abstract available
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccination Hesitancy
Vaccines*
Substances
COVID-19 Vaccines
Vaccines